Cargando…

Consensus Report on Shigella Controlled Human Infection Model: Conduct of Studies

Shigella causes morbidity and mortality worldwide, primarily affecting young children living in low-resource settings. It is also of great concern due to increasing antibiotic resistance, and is a priority organism for the World Health Organization. A Shigella vaccine would decrease the morbidity an...

Descripción completa

Detalles Bibliográficos
Autores principales:	Talaat, Kawsar R, Bourgeois, A Louis, Frenck, Robert W, Chen, Wilbur H, MacLennan, Calman A, Riddle, Mark S, Suvarnapunya, Akamol E, Brubaker, Jessica L, Kotloff, Karen L, Porter, Chad K
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2019
Materias:	Supplement Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6901126/ https://www.ncbi.nlm.nih.gov/pubmed/31816068 http://dx.doi.org/10.1093/cid/ciz892

Ejemplares similares

Consensus Report on Shigella Controlled Human Infection Model: Clinical Endpoints
por: MacLennan, Calman A, et al.
Publicado: (2019)

Consensus Report on Shigella Controlled Human Infection Model: Introduction and Overview
por: MacLennan, Calman A, et al.
Publicado: (2019)

Consensus Report on Shigella Controlled Human Infection Model: Immunological Assays
por: Kaminski, Robert W, et al.
Publicado: (2019)

Critical Needs in Advancing Shigella Vaccines for Global Health
por: MacLennan, Calman A, et al.
Publicado: (2021)

Shigella-Specific Immune Profiles Induced after Parenteral Immunization or Oral Challenge with Either Shigella flexneri 2a or Shigella sonnei
por: Clarkson, Kristen A., et al.
Publicado: (2021)

Frontiers in Shigella Vaccine Development
por: MacLennan, Calman Alexander, et al.
Publicado: (2022)

Immune Response Characterization after Controlled Infection with Lyophilized Shigella sonnei 53G
por: Clarkson, Kristen A., et al.
Publicado: (2020)

The Shigella Vaccines Pipeline
por: MacLennan, Calman Alexander, et al.
Publicado: (2022)

Establishment of a Controlled Human Infection Model with a Lyophilized Strain of Shigella sonnei 53G
por: Frenck, Robert W., et al.
Publicado: (2020)

Human challenge study with a Shigella bioconjugate vaccine: Analyses of clinical efficacy and correlate of protection
por: Talaat, Kawsar R., et al.
Publicado: (2021)

Clinical endpoints in the controlled human challenge model for Shigella: A call for standardization and the development of a disease severity score
por: Porter, Chad K., et al.
Publicado: (2018)

Immune response characterization in a human challenge study with a Shigella flexneri 2a bioconjugate vaccine
por: Clarkson, Kristen A., et al.
Publicado: (2021)

Consequences of Shigella infection in young children: a systematic review
por: Libby, Tanya E., et al.
Publicado: (2023)

Pivotal Shigella Vaccine Efficacy Trials—Study Design Considerations from a Shigella Vaccine Trial Design Working Group
por: Pavlinac, Patricia B., et al.
Publicado: (2022)

Salmonella Combination Vaccines: Moving Beyond Typhoid
por: MacLennan, Calman A, et al.
Publicado: (2023)

Typhoid in India: An Age-old Problem With an Existing Solution
por: Kumar, Supriya, et al.
Publicado: (2021)

Clinical and regulatory development strategies for Shigella vaccines intended for children younger than 5 years in low-income and middle-income countries
por: Giersing, Birgitte K, et al.
Publicado: (2023)

Typhoid Conjugate Vaccines and Enteric Fever Control: Where to Next?
por: Steele, A Duncan, et al.
Publicado: (2020)

Threshold protective levels of serum IgG to Shigella lipopolysaccharide: re-analysis of Shigella vaccine trials data
por: Cohen, Dani, et al.
Publicado: (2023)

Editorial Commentary: Out of Africa: Links Between Invasive Nontyphoidal Salmonella Disease, Typhoid Fever, and Malaria
por: MacLennan, Calman A.
Publicado: (2014)

Antibodies and Protection Against Invasive Salmonella Disease
por: MacLennan, Calman A.
Publicado: (2014)

An O Antigen Capsule Modulates Bacterial Pathogenesis in Shigella sonnei
por: Caboni, Mariaelena, et al.
Publicado: (2015)

Shigella in Africa: New Insights From the Vaccine Impact on Diarrhea in Africa (VIDA) Study
por: Kasumba, Irene N, et al.
Publicado: (2023)

Refinement of the CS6-expressing enterotoxigenic Escherichia coli strain B7A human challenge model: A randomized trial
por: Talaat, Kawsar R., et al.
Publicado: (2020)

Leukocyte counts and lymphocyte subsets in relation to pregnancy and HIV infection in Malawian women
por: Mandala, Wilson L., et al.
Publicado: (2017)

Age- and sex-related changes in hematological parameters in healthy Malawians
por: Mandala, Wilson L, et al.
Publicado: (2017)

Impact and Control of Sugar Size in Glycoconjugate Vaccines
por: Stefanetti, Giuseppe, et al.
Publicado: (2022)

Exploring the variables influencing the immune response of traditional and innovative glycoconjugate vaccines
por: Micoli, Francesca, et al.
Publicado: (2023)

Lymphocyte subsets in healthy Malawians: Implications for immunologic assessment of HIV infection in Africa
por: Mandala, Wilson L., et al.
Publicado: (2010)

Vaccines against invasive Salmonella disease: Current status and future directions
por: MacLennan, Calman A, et al.
Publicado: (2014)

A Systematic Review of the Incidence, Risk Factors and Case Fatality Rates of Invasive Nontyphoidal Salmonella (iNTS) Disease in Africa (1966 to 2014)
por: Uche, Ifeanyi Valentine, et al.
Publicado: (2017)

Efficacy, safety, and immunogenicity of the Shigella sonnei 1790GAHB GMMA candidate vaccine: Results from a phase 2b randomized, placebo-controlled challenge study in adults
por: Frenck, Robert W., et al.
Publicado: (2021)

Modulation of Endotoxicity of Shigella Generalized Modules for Membrane Antigens (GMMA) by Genetic Lipid A Modifications: RELATIVE ACTIVATION OF TLR4 AND TLR2 PATHWAYS IN DIFFERENT MUTANTS
por: Rossi, Omar, et al.
Publicado: (2014)

Morbidity and mortality due to shigella and enterotoxigenic Escherichia coli diarrhoea: the Global Burden of Disease Study 1990–2016
por: Khalil, Ibrahim A, et al.
Publicado: (2018)

US Cystic Fibrosis Foundation and European Cystic Fibrosis Society consensus recommendations for the management of non-tuberculous mycobacteria in individuals with cystic fibrosis
por: Floto, R Andres, et al.
Publicado: (2016)

The Stability of Complement-Mediated Bactericidal Activity in Human Serum against Salmonella
por: O’Shaughnessy, Colette M., et al.
Publicado: (2012)

Early Interferon-γ Production in Human Lymphocyte Subsets in Response to Nontyphoidal Salmonella Demonstrates Inherent Capacity in Innate Cells
por: Nyirenda, Tonney S., et al.
Publicado: (2010)

Severe anaemia, iron deficiency, and susceptibility to invasive bacterial infections
por: Abuga, Kelvin M., et al.
Publicado: (2023)

Characterization of vaccine antigens of meningococcal serogroup W isolates from Ghana and Burkina Faso from 2003 to 2009
por: Ispasanie, Emma, et al.
Publicado: (2014)

How Do We Meet the Supportive Care and Information Needs of Those Living With and Beyond Bladder Cancer?
por: MacLennan, Sara Jane, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_f1rkj6ov6o7qj0ommkb8d2h9ue